Rhodamine 123

ATP binding cassette subfamily B member 1 ; Homo sapiens







470 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
351 12469329 Effect of zolpidem on human cytochrome P450 activity, and on transport mediated by P-glycoprotein. 2002 Dec 1
352 15618688 mRNA expression and amino acid transport characteristics of cultured human brain microvascular endothelial cells (hBME). 2002 2
353 21782616 Monolayers of IEC-18 cells as an in vitro model for screening the passive transcellular and paracellular transport across the intestinal barrier: comparison of active and passive transport with the human colon carcinoma Caco-2 cell line. 2002 Jul 1
354 11288109 P-glycoprotein efflux pump expression and activity in Calu-3 cells. 2001 May 5
355 11303042 Contribution of P-glycoprotein to the enhancing effects of dimethyl-beta-cyclodextrin on oral bioavailability of tacrolimus. 2001 May 1
356 11336351 A human lymphocyte based ex vivo assay to study the effect of drugs on P-glycoprotein (P-gp) function. 2001 Jan 1
357 11337555 In vitro and in vivo tracer characteristics of an established multidrug-resistant human colon cancer cell line. 2001 Apr 1
358 11369657 MDR1 gene-related clonal selection and P-glycoprotein function and expression in relapsed or refractory acute myeloid leukemia. 2001 Jun 1 1
359 11434506 The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells. 2001 Jun 3
360 11468419 HIV-protease inhibitors contribute to P-glycoprotein efflux function defect in peripheral blood lymphocytes from HIV-positive patients receiving HAART. 2001 Aug 1 2
361 11472365 Evidence that natural killer cells express mini P-glycoproteins but not classic 170 kDa P-glycoprotein. 2001 Jul 1
362 11499549 P-glycoprotein in HK-2 proximal tubule cell line. 2001 May-Jul 2
363 11504769 Effects of orally active taxanes on P-glycoprotein modulation and colon and breast carcinoma drug resistance. 2001 Aug 15 2
364 11557130 Expression of MRP1 and related transporters in human lung cells in culture. 2001 Oct 5 1
365 11576779 Modulation of P-glycoprotein activity in Calu-3 cells using steroids and beta-ligands. 2001 Oct 9 6
366 11697504 All-trans retinoic acid (ATRA) differentiates acute promyelocytic leukemia cells independently of P-glycoprotein (P-gp) related multidrug resistance. 2001 Aug 2
367 11697747 Influence of IL-6 on MDR and MRP-mediated multidrug resistance in human hepatoma cells. 2001 Oct 1
368 11739235 Saint John's wort: an in vitro analysis of P-glycoprotein induction due to extended exposure. 2001 Dec 2
369 11762554 P-glycoprotein (P-gp) is upregulated in peripheral T-cell subsets from solid organ transplant recipients. 2001 Dec 2
370 11780384 Reversing drug resistance in the ovarian carcinoma cell line SKOV3/mdr1 in vitro by antisense oligodeoxynucleotides. 2001 Sep 3
371 10783827 Simultaneous measurement of cellular P-glycoprotein content and function by multiparametric flow-cytometry. 2000 Apr 2
372 10837354 Role of multidrug resistance P-glycoprotein in the secretion of aldosterone by human adrenal NCI-H295 cells. 2000 Jun 2
373 10897123 Clinical significance of P-glycoprotein expression and function for response to induction chemotherapy, relapse rate and overall survival in acute leukemia. 2000 Jul 2
374 10912574 Evaluation of toremifene for reversal of multidrug resistance in renal cell cancer patients treated with vinblastine. 2000 1
375 10930993 Constitutive expression levels of CD95 and Bcl-2 as well as CD95 function and spontaneous apoptosis in vitro do not predict the response to induction chemotherapy and relapse rate in childhood acute lymphoblastic leukaemia. 2000 Jul 2
376 10955805 P-glycoprotein and multidrug resistance protein activities in relation to treatment outcome in acute myeloid leukemia. 2000 Aug 2
377 11042226 Specificity of doxorubicin versus rhodamine-123 in assessing P-glycoprotein functionality in the LLC-PK1, LLC-PK1:MDR1 and Caco-2 cell lines. 2000 Sep 4
378 11106230 Phase I trial of XR9576 in healthy volunteers demonstrates modulation of P-glycoprotein in CD56+ lymphocytes after oral and intravenous administration. 2000 Nov 4
379 11122104 Contrasting in vitro effects for the combination of fludarabine, cytosine arabinoside (Ara-C) and granulocyte colony-stimulating factor (FLAG) compared with daunorubicin and Ara-C in P-glycoprotein-positive and P-glycoprotein-negative acute myeloblastic leukaemia. 2000 Nov 1
380 11144235 The effect of fatty acids and analogues upon intracellular levels of doxorubicin in cells displaying P-glycoprotein mediated multidrug resistance. 2000 1
381 11197207 Multidrug resistance of acute leukemia and a strategy to overcome it. 2000 Dec 2
382 11775252 Expression of the human multidrug resistance gene mdr1 in leukemic cells and its application in studying P-glycoprotein antagonists. 2000 Mar 5
383 10088973 Correlation of rhodamine 123 efflux by neoplastic plasma cells with clinical and biological characteristics of multiple myeloma. 1999 Feb 15 1
384 10226171 Drug extrusion, 125I- efflux and the control of intracellular [Ca2+] in drug-resistant ovarian epithelial cells. 1999 Mar 1
385 10368668 Cimetidine enhances the antiproliferative effect of 5-fluorouracil on colon carcinoma SW620. 1999 Mar-Apr 2
386 10399829 Follicle-like structures formed by intestinal cell lines derived from the HT29-D4 adenocarcinoma cell line: morphological and functional characterization. 1999 Mar 1
387 10399951 Tumor-specific expression of anti-mdr1 ribozyme selectively restores chemosensitivity in multidrug-resistant colon-adenocarcinoma cells. 1999 Jul 30 6
388 10413294 Interaction of the P-glycoprotein multidrug transporter (MDR1) with high affinity peptide chemosensitizers in isolated membranes, reconstituted systems, and intact cells. 1999 Aug 15 1
389 10448079 Transport of phosphatidylcholine in MDR3-negative epithelial cell lines via drug-induced MDR1 P-glycoprotein. 1999 Aug 19 2
390 10500780 Assessment of P-glycoprotein expression by immunocytochemistry and flow cytometry using two different monoclonal antibodies coupled with functional efflux analysis in 34 patients with acute myeloid leukemia. 1999 1
391 10502353 Polyion complex micelles with protein-modified corona for receptor-mediated delivery of oligonucleotides into cells. 1999 Sep-Oct 2
392 10509562 Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors. 1999 Sep 10 4
393 10532592 Interferon-gamma up-regulates expression and activity of P-glycoprotein in human peripheral blood monocyte-derived macrophages. 1999 Oct 1
394 10557064 Bcl-2, bax and bcl-xL expression in human sensitive and resistant leukemia cell lines. 1999 Nov 1
395 10602414 Clinical significance of CD95, Bcl-2 and Bax expression and CD95 function in adult de novo acute myeloid leukemia in context of P-glycoprotein function, maturation stage, and cytogenetics. 1999 Dec 1
396 10725785 Influence of IGF-I and cell density on MDR1 expression in the T-lymphoblastoid cell line CCRF-CEM. 1999 1
397 9504633 Multidrug resistance analysis in lymphoproliferative disease of large granular lymphocytes. 1998 Mar 1
398 9551613 Efficient transduction of human hematopoietic cells with the human multidrug resistance gene 1 via SV40 pseudovirions. 1998 Mar 20 1
399 9594630 [Quantitative analysis of multidrug resistance phenotype in hematological malignancies]. 1998 Apr 4
400 9625436 The bisbenzylisoquinoline alkaloids, tetrandine and fangchinoline, enhance the cytotoxicity of multidrug resistance-related drugs via modulation of P-glycoprotein. 1998 Mar 1